## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopaβinduced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5β25 mg daily, because
Clozapine for dopaminergic-induced paraphilias in Parkinson's disease
β Scribed by Hubert H. Fernandez; Raymon Durso
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 259 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Existing and emerging strategies for managing Lβdopaβinduced dyskinesias (LIDs) in patients with Parkinson disease have involved either delaying the introduction of Lβdopa therapy, treatment with an antidyskinetic agent, using a therapy or delivery system that can provide continuous dop
We appreciate the careful reading of our manuscript by Okun and colleagues. 1 However, their letter contains a number of inaccuracies that require correction. We clearly state
## Abstract Clozapine is an atypical neuroleptic medication that is free of parkinsonian side effects and that has been reported to ameliorate the tremor of Parkinson's disease. We report (with videotape illustration) the dramatic improvement of severe yet classic rest tremors in one elderly nonpsy